Skip to main content
. 2022 Jan 21;10(3):790–801. doi: 10.12998/wjcc.v10.i3.790

Table 2.

Grouping analysis of the relationship between tumor mutation burden and overall survival

Median survival (mo)
Log-rank test

TMB-high
TMB-low
HR
P value
Tumor grade
Well differentiated - (n = 5) 56.1 (n = 10) 0.64 (0.15-2.27) 0.582
Moderately differentiated 26.5 (n = 79) 42.5 (n = 134) 1.46 (1.02-2.08) 0.026
Poorly differentiated 20.2 (n = 52) 29.8 (n = 82) 1.72 (1.11-2.66) 0.007
Disease progression
Solitary liver tumor 55.1 (n = 44) 69.4 (n = 93) 1.42 (0.85-2.38) 0.140
Multifocal liver disease 24.4 (n = 31) 40.6 (n = 46) 1.85 (1.00-3.43) 0.026
Metastatic disease 15.5 (n = 65) 15.8 (n = 100) 1.17 (0.83-1.66) 0.357
Tumor resection
Resected 36.6 (n = 67) 61.5 (n = 127) 1.77 (1.17-2.66) 0.002
Unresected 17.5 (n = 73) 17.7 (n = 112) 1.13 (0.81-1.59) 0.461

TMB: Tumor mutation burden.